Zobrazeno 1 - 10
of 50
pro vyhledávání: '"FUMIHIKO MOURI"'
Autor:
Kodai Kawaji, Seiji Kurata, Katsuhisa Matsuo, Hiroaki Miyoshi, Jun Akiba, Fumihiko Mouri, Akiko Sumi, Kiminori Fujimoto, Toshi Abe
Publikováno v:
Asia Oceania Journal of Nuclear Medicine and Biology, Vol 12, Iss 1, Pp 52-56 (2024)
18F-FDG PET/CT is regarded as a modality utilized for the purpose of lesion localization, staging and assessment of treatment response in patients with lymphoma. However, it is difficult that we diagnose among multifocal lymphoma, IgG4-related diseas
Externí odkaz:
https://doaj.org/article/6b652ff414994059b861559e129cb76e
Autor:
Shuki Oya, Hidetoshi Ozawa, Takayuki Nakamura, Yoshimi Maehiro, Yusuke Takaki, Yoshinobu Fukuyama, Yoshitaka Yamasaki, Maki Yamaguchi, Kazutoshi Aoyama, Fumihiko Mouri, Koji Nagafuji
Publikováno v:
HemaSphere, Vol 7, p e53072ea (2023)
Externí odkaz:
https://doaj.org/article/66b41367bcc84ceea53108b134a79bc7
Autor:
Kodai kawaji, Seiji Kurata, Katsuhisa Matsuo, Hiroaki Miyoshi, Jun Akiba, Fumihiko Mouri, Akiko Sumi, Kiminori Fujimoto, Toshi Abe
Publikováno v:
Asia Oceania Journal of Nuclear Medicine & Biology; Jan2024, Vol. 12 Issue 1, p52-56, 5p
Autor:
Koichi, Osaki, Yoko, Sogabe, Ritsuko, Seki, Takayuki, Nakamura, Satoshi, Morishige, Eijiro, Oku, Yuka, Takata, Fumihiko, Mouri, Koji, Yoshimoto, Koji, Nagafuji, Takashi, Okamura
Publikováno v:
The Kurume medical journal. 67(2.3)
We investigated the molecular basis of factor VII (FVII) deficiency in a Japanese patient and identified compound heterozygous mutations. Factor VII activity and antigen levels in the patient were less than 5.0% and 6.5% of controls, respectively. Al
Autor:
Shuki Oya, Hidetoshi Ozawa, Yoshimi Maehiro, Takayuki Nakamura, Yusuke Takaki, Toshinobu Fukuyama, Yoshitaka Yamasaki, Maki Yamaguchi, Kazutoshi Aoyama, Fumihiko Mouri, Koji Nagafuji
Publikováno v:
Leukemia Research. 130:107313
Autor:
Kazutoshi, Aoyama, Yoshitaka, Yamasaki, Fumihiko, Mouri, Yoshimi, Maehiro, Yusuke, Takaki, Shuki, Oya, Takayuki, Nakamura, Satoshi, Morishige, Maki, Yamaguchi, Koji, Nagafuji
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 63(7)
FMS-like tyrosine kinase 3 (FLT3) inhibitors improve the prognosis of FLT3-internal tandem duplication (ITD)-positive acute myeloid leukemia (AML). Case 1 is a 47-year-old male patient who presented with a white blood cell count (WBC) of 95,700/ml wi
Autor:
Kazutoshi Aoyama, Koichi Osaki, Kenta Murotani, Yoshitaka Yamasaki, Takuro Imai, Takayuki Nakamura, Maki Yamaguchi, Yusuke Takagi, Takuma Hazama, Shuki Oya, Fumihiko Mouri, Koji Nagafuji, Koichi Egashira, Satoshi Morishige
Publikováno v:
Journal of Hematopoietic Cell Transplantation. 10:129-135
Autor:
Shuki Oya, Hidetoshi Ozawa, Takayuki Nakamura, Toshinobu Fukuyama, Yusuke Takaki, Yoshitaka Yamasaki, Kazutoshi Aoyama, Maki Yamaguchi, Fumihiko Mouri, Koji Nagafuji
Publikováno v:
Blood. 140:11784-11785
Autor:
Satoshi, Morishige, Yoshitaka, Yamasaki, Shuki, Oya, Takayuki, Nakamura, Maki, Yamaguchi, Kazutoshi, Aoyama, Fumihiko, Mouri, Yasuko, Mizushima, Osamu, Nakashima, Koji, Nagafuji
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 63(4)
Inotuzumab ozogamicin (InO) was administered in three cases of relapsed/refractory adult acute lymphoblastic leukemia (ALL) before allogeneic hematopoietic stem cell transplantation (allo-SCT). One case developed extremely severe sinusoidal obstructi
Autor:
KOICHI OSAKI, YOKO SOGABE, RITSUKO SEKI, TAKAYUKI NAKAMURA, SATOSHI MORISHIGE, EIJIRO OKU, YUKA TAKATA, FUMIHIKO MOURI, KOJI YOSHIMOTO, KOJI NAGAFUJI, TAKASHI OKAMURA
Publikováno v:
The Kurume Medical Journal. 67:83-89